ImportantCompany Update
The company has announced a board meeting to consider and approve the financial results for the quarter and half-year.
Emmessar Biotech & Nutrition Ltd524768 · Filed with the exchange
The board will also discuss a proposal to raise funds by issuing equity shares or other convertible securities on a preferential basis.
This fundraising plan requires shareholder approval at an Extra-ordinary General Meeting.
This indicates the company is exploring capital-raising options, a key development for investors regarding its future financial structure.
No comments yet. Be the first.